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Several variants of ﬁxed drug eruptions (FDEs) have been
deﬁned based on their morphologicaleclinical features. These
include pigmenting, generalized, linear, wandering, nonpigment-
ing, bullous, urticarial, erythema dyschromicum perstans-like,
oral, and psoriasiform FDE, and vulvitis.1 Fluoroquinolone-
induced FDEs reported in the literature are usually localized
FDEs.2,3 Nonbullous generalized FDE following treatment with
ciproﬂoxacin and levoﬂoxacin and a few cases of generalized
bullous FDE (GBDFE) after ciproﬂoxacin intake have also been
reported.4e6 Here we present a case of GBFDE caused by
levoﬂoxacin.
An 87-year-old man who had been treated for chronic obstruc-
tive pulmonary disease with bronchodilators for 20 years was
referred to our outpatient clinic for evaluation of an eruption of 4
days' duration. He had been treated with levoﬂoxacin 500 mg
tablet, 5 days previously due to the exacerbation of chronic obstruc-
tive pulmonary disease and acute bronchitis. He had not received
any other medications for exacerbation. He began itching over
the back and legs followed by a burning sensation and subsequent
development of a few ﬂuid ﬁlled purplish lesions. Multiple
erythematous pigmented patches and a few bullous eruptions on
the back and gluteal region had developed 1 day after the ﬁrst
parenteral intake of levoﬂoxacin. He did not have erosions over
the lips and buccal mucosa. He had a preceding history of a similar
but less severe bullous reaction after taking the same drug in the
same locations 4 months previously. There was no history of any
other oral drug intake. On physical examination purplish, dusky
erythematous patches and a few bullae were seen on the back
and left gluteal region. Pseudo-Nikolsky's sign was positive on
the pigmented areas (Figure 1). His vital signs were within normal
limits.
The patient was hospitalized with the differential diagnosis of
generalized bullous drug eruption, bullous pemphigoid, and Ste-
venseJohnson syndrome. Histopathological examination from a
droopy bulla showed necrotic keratinocytes in the epidermis, sub-
epidermal clefting, perivascular mixed inﬂammatory inﬁltrate con-
taining eosinophils, and prominent pigment incontinence in the
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nation revealed a leukocyte count of 8.5  109/L with mild eosino-
philia. Biochemical proﬁles showed renal dysfunction with high
values of serum creatinine, 1.35 mg/dL (normal 0.7e1.2 mg/dL)
and blood urea nitrogen, 25 mg/dL (normal 6e20 mg/dL). C-reac-
tive protein was 56.27 mg/dL (normal < 5 mg/dL), sedimentation
rate was 46 mm/h (normal < 20 mm/h) and other values were
within normal limits.
Based on the clinical and histological course, the diagnosis of
GBFDE due to levoﬂoxacin was made. A short course of topical clo-
betasol 17epropionate balm therapy was given to the patient. All
lesions recovered thoroughly in 2 weeks by leaving residual hyper-
pigmentation of the involved skin sites.
In FDE, lesions recur at the same sites or may increase when the
offending drug is re-administered and rarely advances to GBFDE.
GBFDE begins within hours after the drug intake.5 GBFDE is charac-
terized by extensive blisters and erosions on the whole body in
addition to typical FDE reactions.7 In GBFDE, mucosal involvement
is usually absent or less and the clinical course is favorable with
rapid resolution after drug discontinuation.5,7 However, the prog-
nosis of GBFDE may be unfavorable in older patients, particularly
in those with comorbidities.8
GBFDE may be mistaken clinically or histopathologically for
StevenseJohnson syndrome/toxic epidermal necrolysis, but it
is reported that, clinically, GBFDE has shorter latent term and
less mucosal containment, and, histopathologically, has more
eosinophil inﬁltration and more dermal melanophages.7 In our
patient, history of previous less severe bullous reaction in the
same locations, absence of mucosal involvement, lack of typical
target lesions, absence of systemic involvement, fast healing
with residual hyperpigmentation, relationship with the drug
intake, typical histopathological ﬁndings were the clues for
the diagnosis of GBFDE. The oral challenge test is the conﬁrma-
tive method for establishing the causative agent in FDE.5,6 How-
ever, our patient was very old, he had respiratory insufﬁciency,
and his lesions were widespread and severe, so we did not want
to increase the risk of complications by oral challenge test. The
ﬁrst step in the treatment is discontinuing the liable drug. Usu-
ally, systemic antihistamines and topical corticosteroids may be
sufﬁcient.3
In conclusion, we believe that clinicians must keep in mind that
levoﬂoxacin, which is a commonly prescribed antibiotic, may result
in GBFDE. It can be misdiagnosed as other blistering diseases. It is
important to make the true diagnosis of GBFDE, especially in
elderly patients, to avoid unnecessary systemic steroid use.er Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Multiple well-circumscribed, purplish-livid patches and eroded areas on the back and (B) close-up view of ﬂaccid bullae and erosions on the left buttock.
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